trial

Effect of N-acetylcysteine on Brain Glutamate

NCTId NCT02483130
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 20 (actual)
Sponsored by King's College London
Primary completion 2017-02-28
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-06
Primary completion
2017-02-28
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
N-acetylcysteine

Sponsors

King's College LondonLead Sponsor

Investigators

1
James H McCabePrincipal Investigator

Sites

1 total
Denmark Hill, United Kingdom

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2017-02-28
Status
COMPLETED
relationships
The graph out of here
drug
N-acetylcysteine
drug
lead_sponsor
King's College London
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
James H McCabe
person